Revised standards for statistical evidence by Valen E. Johnson
Revised standards for statistical evidence
Valen E. Johnson1
Department of Statistics, Texas A&M University, College Station, TX 77843-3143
Edited by Adrian E. Raftery, University of Washington, Seattle, WA, and approved October 9, 2013 (received for review July 18, 2013)
Recent advances in Bayesian hypothesis testing have led to the
development of uniformly most powerful Bayesian tests, which
represent an objective, default class of Bayesian hypothesis tests
that have the same rejection regions as classical signiﬁcance tests.
Based on the correspondence between these two classes of tests,
it is possible to equate the size of classical hypothesis tests with
evidence thresholds in Bayesian tests, and to equate P values with
Bayes factors. An examination of these connections suggest that
recent concerns over the lack of reproducibility of scientiﬁc studies
can be attributed largely to the conduct of signiﬁcance tests at
unjustiﬁably high levels of signiﬁcance. To correct this problem,
evidence thresholds required for the declaration of a signiﬁcant
ﬁnding should be increased to 25–50:1, and to 100–200:1 for the
declaration of a highly signiﬁcant ﬁnding. In terms of classical
hypothesis tests, these evidence standards mandate the conduct
of tests at the 0.005 or 0.001 level of signiﬁcance.
Reproducibility of scientiﬁc research is critical to the scientiﬁcendeavor, so the apparent lack of reproducibility threatens
the credibility of the scientiﬁc enterprise (e.g., refs. 1 and 2).
Unfortunately, concern over the nonreproducibility of scientiﬁc
studies has become so pervasive that a Web site, Retraction Watch,
has been established to monitor the large number of retracted
papers, and methodology for detecting ﬂawed studies has de-
veloped nearly into a scientiﬁc discipline of its own (e.g., refs. 3–9).
Nonreproducibility in scientiﬁc studies can be attributed to
a number of factors, including poor research designs, ﬂawed
statistical analyses, and scientiﬁc misconduct. The focus of this
article, however, is the resolution of that component of the prob-
lem that can be attributed simply to the routine use of widely ac-
cepted statistical testing procedures.
Claims of novel research ﬁndings are generally based on the
outcomes of statistical hypothesis tests, which are normally con-
ducted under one of two statistical paradigms. Most commonly,
hypothesis tests are performed under the classical, or frequentist,
paradigm. In this approach, a “signiﬁcant” ﬁnding is declared
when the value of a test statistic exceeds a speciﬁed threshold.
Values of the test statistic above this threshold deﬁne the test’s
rejection region. The signiﬁcance level α of the test is deﬁned to be
the maximum probability that the test statistic falls into the re-
jection region when the null hypothesis—representing standard
theory—is true. By long-standing convention (10), a value of α =
0.05 deﬁnes a signiﬁcant ﬁnding. The P value from a classical test
is the maximum probability of observing a test statistic as extreme,
or more extreme, than the value that was actually observed, given
that the null hypothesis is true.
The second approach for performing hypothesis tests follows
from the Bayesian paradigm and focuses on the calculation of
the posterior odds that the alternative hypotheses is true, given
the observed data and any available prior information (e.g., refs.
11 and 12). From Bayes theorem, the posterior odds in favor of
the alternative hypothesis equals the prior odds assigned in favor
of the alternative hypotheses, multiplied by the Bayes factor. In
the case of simple null and alternative hypotheses, the Bayes factor
represents the ratio of the sampling density of the data evaluated
under the alternative hypothesis to the sampling density of the
data evaluated under the null hypothesis. That is, it represents the
relative probability assigned to the data by the two hypotheses. For
composite hypotheses, the Bayes factor represents the ratio of
the average value of the sampling density of the observed data
under each of the two hypotheses, averaged with respect to
the prior density speciﬁed on the unknown parameters under
each hypothesis.
Paradoxically, the two approaches toward hypothesis testing
often produce results that are seemingly incompatible (13–15).
For instance, many statisticians have noted that P values of 0.05
may correspond to Bayes factors that only favor the alternative
hypothesis by odds of 3 or 4–1 (13–15). This apparent discrep-
ancy stems from the fact that the two paradigms for hypothesis
testing are based on the calculation of different probabilities:
P values and signiﬁcance tests are based on calculating the prob-
ability of observing test statistics that are as extreme or more
extreme than the test statistic actually observed, whereas Bayes
factors represent the relative probability assigned to the ob-
served data under each of the competing hypotheses. The latter
comparison is perhaps more natural because it relates directly to
the posterior probability that each hypothesis is true. However,
deﬁning a Bayes factor requires the speciﬁcation of both a null
hypothesis and an alternative hypothesis, and in many circum-
stances there is no objective mechanism for deﬁning an alter-
native hypothesis. The deﬁnition of the alternative hypothesis
therefore involves an element of subjectivity, and it is for this
reason that scientists generally eschew the Bayesian approach
toward hypothesis testing. Efforts to remove this hurdle con-
tinue, however, and recent studies of the use of Bayes factors in
the social sciences include refs. 16–20.
Recently, Johnson (21) proposed a new method for specifying
alternative hypotheses. When used to test simple null hypotheses
in common testing scenarios, this method produces default
Bayesian procedures that are uniformly most powerful in the
sense that they maximize the probability that the Bayes factor in
favor of the alternative hypothesis exceeds a speciﬁed threshold.
A critical feature of these Bayesian tests is that their rejection
regions can be matched exactly to the rejection regions of clas-
sical hypothesis tests. This correspondence is important because
it provides a direct connection between signiﬁcance levels,
P values, and Bayes factors, thus making it possible to objectively
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examine the strength of evidence provided against a null hy-
pothesis as a function of a P value or signiﬁcance level.
Results
Let f ðxjθÞ denote the sampling density of the data x under both
the null (H0) and alternative (H1) hypotheses. For i = 0, 1, let
πiðθÞ denote the prior density assigned to the unknown param-
eter θ belonging to Θ under hypothesis Hi, let P(Hi) denote the
prior probability assigned to hypothesis Hi, and let miðxÞ denote
the marginal density of the data under hypothesis Hi, i.e.,
miðxÞ=
Z
Θ
f ðxjθÞπiðθÞdθ: [1]
The Bayes factor in favor of the alternative hypothesis is deﬁned
as BF10ðxÞ=m1ðxÞ=m0ðxÞ.
A condition of equipoise is said to apply if p(H0) = p(H1) =
0.5. It is assumed that no subjectivity is involved in the speciﬁca-
tion of the null hypothesis. Under these assumptions, a uniformly
most powerful Bayesian test (UMPBT) for evidence threshold γ,
denoted by UMPBT(γ), may be deﬁned as follows (21).
Deﬁnition. A UMPBT for evidence threshold γ > 0 in favor of
the alternative hypothesis H1 against a ﬁxed null hypothesis H0 is
a Bayesian hypothesis test in which the Bayes factor for the test
satisﬁes the following inequality for any θt ∈Θ and for all alter-
native hypotheses H1′ : θ∼ π1′ðθÞ:
Pθt ½BF10ðxÞ> γ≥Pθt ½BF1′0ðxÞ> γ: [2]
That is, the UMPBT(γ) is a Bayesian test in which the alter-
native hypothesis is speciﬁed so as to maximize the probability
that the Bayes factor BF10ðxÞ exceeds the evidence threshold γ
for all possible values of the data generating parameter θt.
Under mild regularity conditions, Johnson (21) demonstrated
that UMPBTs exist for testing the values of parameters in one-
parameter exponential family models. Such tests include tests of
a normal mean (with known variance) and a binomial proportion.
In SI Text, UMPBTs are derived for tests of the difference of
normal means, and for testing whether the noncentrality param-
eter of a χ2 random variable on one degree of freedom is equal
to 0. The form of alternative hypotheses, Bayes factors, rejection
regions, and the relationship between evidence thresholds and
sizes of equivalent frequentist tests are provided in Table S1.
The construction of UMPBTs is perhaps most easily illus-
trated in a z test for the mean μ of a random sample of normal
observations with known variance σ2. From Table S1, a one-sided
UMPBT of the null hypothesis H0 : μ= 0 against alternatives that
specify that μ> 0 is obtained by specifying the alternative hy-
pothesis to be
H1 : μ1 = σ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2logðγÞ
n
r
:
For z=
ﬃﬃﬃ
n
p
x=σ, the Bayes factor for this test is
BF10ðzÞ= exp
h
z
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2logðγÞ
p
− logðγÞ
i
:
By setting the evidence threshold γ = 3:87, the rejection region of
the resulting test exactly matches the rejection region of a one-
sided 5% signiﬁcance test. That is, the Bayes factor for this test
exceeds 3.87 whenever the sample mean of the data, x, exceeds
1:645σ=
ﬃﬃﬃ
n
p
, the rejection region for a classical one-sided 5% test.
If x= 1:645σ=
ﬃﬃﬃ
n
p
, then the UMPBT produces a Bayes factor that
achieves the bounds described in ref. 13. Conversely if x= 0, the
Bayes factor in favor of the alternative hypothesis is 1/3.87 = 0.258,
which illustrates that UMPBTs—unlike P values—provide evi-
dence in favor of both true null and true alternative hypotheses.
This example highlights several properties of UMPBTs. First,
the prior densities that deﬁne one-sided UMPBT alternatives
concentrate their mass on a single point in the parameter space.
Second, the distance between the null parameter value and the
alternative parameter value is typically Oðn−1=2Þ, which means
that UMPBTs share certain large sample properties with clas-
sical hypothesis tests. The implications of these properties are
discussed further in SI Text and in ref. 21.
Unfortunately, UMPBTs do not exist for testing a normal
mean or difference in means when the observational variance σ2
is not known. However, if σ2 is unknown and an inverse gamma
prior distribution is imposed, then the probability that the Bayes
factor exceeds the evidence threshold γ in a one-sample test can
be expressed as
P½BF10 > γ=P½an < x< bn; [3]
and in a two-sample test as
P½BF10 > γ=P½an < x2 − x1 < bn: [4]
In these expressions, an and bn are functions of the evidence
threshold γ, the population means, and a statistic that is ancillary
to both. Furthermore, bn→∞ as the sample size n becomes large.
For sufﬁciently large n, approximate, data-dependent UMPBTs can
thus be obtained by determining the values of the population means
that minimize an, because minimizing an maximizes the probability
that the sample mean or difference in sample means will exceed an,
regardless of the distribution of the sample means. The resulting
approximate UMPBT tests are useful for examining the connection
between Bayesian evidence thresholds and signiﬁcance levels in
classical t tests. Expressions for the values of the population means
that minimize an for t tests are provided in Table S1.
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Fig. 1. Evidence thresholds and size of corresponding signiﬁcance tests. The
UMPBT and signiﬁcance tests used to construct this plot have the same (z, χ2, and
binomial tests) or approximately the same (t tests) rejection regions. The smooth
curves represent, from Top to Bottom, t tests based on 20, 30, and 60 degrees of
freedom, the z test, and the χ2 test on 1 degree of freedom. The discontinuous
curves reﬂect the correspondence between tests of a binomial proportion based
on 20, 30, or 60 observations when the null hypothesis is p0 = 0.5.
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Because UMBPTs can be used to deﬁne Bayesian tests that
have the same rejection regions as classical signiﬁcance tests, “a
Bayesian using a UMPBT and a frequentist conducting a signif-
icance test will make identical decisions on the basis of the ob-
served data. That is, a decision to reject the null hypothesis at
a speciﬁed signiﬁcance level occurs only when the Bayes factor in
favor of the alternative hypothesis exceeds a speciﬁed evidence
threshold” (21). The close connection between UMPBTs and
signiﬁcance tests thus provides insight into the amount of evi-
dence required to reject a null hypothesis.
To illustrate this connection, curves of the values of the test
sizes (α) and evidence thresholds (γ) that produce matching re-
jection regions for a variety of standard tests have been plotted in
Fig. 1. Included among these are z tests, χ2 tests, t tests, and tests
of a binomial proportion.
The two red boxes in Fig. 1 highlight the correspondence
between signiﬁcance tests conducted at the 5% and 1% levels of
signiﬁcance and evidence thresholds. As this plot shows, the
Bayesian evidence thresholds that correspond to these tests are
quite modest. Evidence thresholds that correspond to 5% tests
range between 3 and 5. This range of evidence falls at the lower
end of the range that Jeffreys (11) calls “substantial evidence,” or
what Kass and Raftery (12) term “positive evidence.” Evidence
thresholds for 1% tests range between 12 and 20, which fall at
the lower end of Jeffreys’ “strong-evidence” category, or the upper
end of Kass and Raftery’s positive-evidence category. If equipoise
applies, the posterior probabilities assigned to null hypotheses
range from ∼0.17 to 0.25 for null hypotheses that are rejected at
the 0.05 level of signiﬁcance, and from about 0.05 to 0.08 for nulls
that are rejected at the 0.01 level of signiﬁcance.
The two blue boxes in Fig. 1 depict the range of evidence
thresholds that correspond to signiﬁcance tests conducted at the
0.005 and 0.001 levels of signiﬁcance. Bayes factors in the range
of 25–50 are required to obtain tests that have rejection regions
that correspond to 0.005 level tests, whereas Bayes factors be-
tween ∼100 and 200 correspond to 0.001 level tests. In Jeffreys’
scheme (11), Bayes factors in the range 25–50 are considered
“strong” evidence in favor of the alternative, and Bayes factors in
the range 100–200 are considered “decisive.” Kass and Raftery
(12) consider Bayes factors between 20 and 150 as “strong”
evidence, and Bayes factors above 150 to be “very strong”
evidence. Thus, according to standard scales of evidence, these
levels of signiﬁcance represent either strong, very strong, or
decisive levels of evidence. If equipoise applies, then the cor-
responding posterior probabilities assigned to null hypotheses
range from ∼0.02 to 0.04 for null hypotheses that are rejected
at the 0.005 level of signiﬁcance, and from about 0.005 to 0.01
for null hypotheses that are rejected at the 0.001 level of
signiﬁcance.
The correspondence between signiﬁcance levels and evidence
thresholds summarized in Fig. 1 describes the theoretical con-
nection between UMPBTs and their classical analogs. It is also
informative to examine this connection in actual hypothesis tests.
To this end, UMPBTs were used to reanalyze the 855 t tests
reported in Psychonomic Bulletin & Review and Journal of Exper-
imental Psychology: Learning, Memory, and Cognition in 2007 (20).
Because exact UMPBTs do not exist for t tests, the evidence
thresholds obtained from the approximate UMPBTs described in
SI Text were obtained by ignoring the upper bound on the re-
jection regions described in Eqs. 3 and 4. From a practical per-
spective, this constraint is only important when the t statistic for
a test is large, and in such cases the null hypothesis can be re-
jected with a high degree of conﬁdence. To avoid this compli-
cation, t statistics larger than the value of the t statistic that
maximizes the Bayes factor in favor of the alternative were ex-
cluded from this analysis. Also, because all tests reported by
Wetzels et al. (20) were two-sided, the approximate two-sided
UMPBTs described in ref. 21 were used in this analysis. The two-
sided tests are obtained by deﬁning the alternative hypothesis so
that it assigns one-half probability to the two alternative hy-
potheses that represent the one-sided UMPBT(2γ) tests.
To compute the approximate UMPBTs for the t statistics
reported in ref. 20, it was assumed that all tests were conducted
at the 5% level of signiﬁcance. The Bayes factors corresponding
to the 765 t statistics that did not exceed the maximum value are
plotted against their P values in Fig. 2.
Fig. 2 shows that there is a strong curvilinear relationship
between the P values of the tests reported in ref. 20 and the
Bayes factors obtained from the UMPBT tests. Furthermore, the
relationship between the P values and Bayes factors is roughly
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Fig. 2. P values versus UMPBT Bayes factors. This plot depicts approximate
Bayes factors derived from 765 t statistics reported by Wetzels et al. (20). A
breakdown of the curvilinear relationship between Bayes factors and
P values occurs in the lower right portion of the plot, which corresponds to
t statistics that produce Bayes factors that are near their maximum value.
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Fig. 3. Histogram of P values that were less than 0.05 and reported in ref. 20.
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equivalent to the relationship observed with test size in Fig. 1. In
this case, P values of 0.05 correspond to Bayes factors around
5, P values of 0.01 correspond to Bayes factors around 20,
P values of 0.005 correspond to Bayes factors around 50, and
P values of 0.001 correspond to Bayes factors around 150. As
before, signiﬁcant (P = 0.05) and highly signiﬁcant (P = 0.01)
P values seem to reﬂect only modest evidence in favor of the
alternative hypotheses.
Discussion
The correspondence between P values and Bayes factors based
on UMPBTs suggest that commonly used thresholds for statis-
tical signiﬁcance represent only moderate evidence against null
hypotheses. Although it is difﬁcult to assess the proportion of all
tested null hypotheses that are actually true, if one assumes that
this proportion is approximately one-half, then these results
suggest that between 17% and 25% of marginally signiﬁcant
scientiﬁc ﬁndings are false. This range of false positives is con-
sistent with nonreproducibility rates reported by others (e.g., ref.
5). If the proportion of true null hypotheses is greater than one-
half, then the proportion of false positives reported in the sci-
entiﬁc literature, and thus the proportion of scientiﬁc studies
that would fail to replicate, is even higher.
In addition, this estimate of the nonreproducibility rate of
scientiﬁc ﬁndings is based on the use of UMPBTs to establish the
rejection regions of Bayesian tests. In general, the use of other
default Bayesian methods to model effect sizes results in even
higher assignments of posterior probability to rejected null hy-
potheses, and thus to even higher estimates of false-positive rates.
This phenomenon is discussed further in SI Text, where Bayes
factors obtained using several other default Bayesian procedures
are compared with UMPBTs (see Fig. S1). These analyses suggest
that the range 17–25% underestimates the actual proportion of
marginally signiﬁcant scientiﬁc ﬁndings that are false.
Finally, it is important to note that this high rate of nonre-
producibility is not the result of scientiﬁc misconduct, publica-
tion bias, ﬁle drawer biases, or ﬂawed statistical designs; it is simply
the consequence of using evidence thresholds that do not repre-
sent sufﬁciently strong evidence in favor of hypothesized effects.
As ﬁnal evidence of the severity of this effect, consider again
the t statistics compiled by Wetzels et al. (20). Although the
P values derived from these statistics cannot be considered
a random sample from any meaningful population, it is none-
theless instructive to examine the distribution of the signiﬁcant
P values derived from these test statistics. A histogram estimate
of this distribution is depicted in Fig. 3.
The P values displayed in Fig. 3 presumably arise from two
types of experiments: experiments in which a true effect was
present and the alternative hypothesis was true, and experiments
in which there was no effect present and the null hypothesis
was true. For the latter experiments, the nominal distribution
of P values is uniformly distributed on the range (0.0, 0.05).
The distribution of P values reported for true alternative hypoth-
eses is, by assumption, skewed to the left. The P values displayed in
this plot thus represent a mixture of a uniform distribution and
some other distribution. Even without resorting to complicated
statistical methods to ﬁt this mixture, the appearance of this his-
togram suggests that many, if not most, of the P values falling
above 0.01 are approximately uniformly distributed. That is, most
of the signiﬁcant P values that fell in the range (0.01–0.05) prob-
ably represent P values that were computed from data in which the
null hypothesis of no effect was true.
These observations, along with the quantitative ﬁndings re-
ported in Results, suggest a simple strategy for improving the
replicability of scientiﬁc research. This strategy includes the
following steps:
(i) Associate statistically signiﬁcant test results with P values
that are less than 0.005. Make 0.005 the default level of
signiﬁcance for setting evidence thresholds in UMPBTs.
(ii) Associate highly signiﬁcant test results with P values that are
less than 0.001.
(iii) When UMPBTs can be deﬁned (or when other default
Bayesian procedures are available), report the Bayes factor
in favor of the alternative hypothesis and the default alter-
native hypothesis that was tested.
Of course, there are costs associated with raising the bar for
statistical signiﬁcance. To achieve 80% power in detecting a
standardized effect size of 0.3 on a normal mean, for instance,
decreasing the threshold for signiﬁcance from 0.05 to 0.005
requires an increase in sample size from 69 to 130 in experimental
designs. To obtain a highly signiﬁcant result, the sample size of a
design must be increased from 112 to 172.
These costs are offset, however, by the dramatic reduction in
the number of scientiﬁc ﬁndings that will fail to replicate. In terms
of evidence, these more stringent criteria will increase the odds
that the data must favor the alternative hypothesis to obtain
a signiﬁcant ﬁnding from ∼3–5:1 to ∼25–50:1, and from ∼12–15:1
to 100–200:1 to obtain a highly signiﬁcant result. If one-half of
scientiﬁcally tested (alternative) hypotheses are true, then these
evidence standards will reduce the probability of rejecting a true
null hypothesis based on a signiﬁcant ﬁnding from ∼20% to less
than 4%, and from ∼7% to less than 1% when based on a highly
signiﬁcant ﬁnding. The more stringent standards will thus reduce
false-positive rates by a factor of 5 or more without requiring even
a doubling of sample sizes.
Finally, reporting the Bayes factor and the alternative hy-
pothesis that was tested will provide scientists with a mechanism
for evaluating the posterior probability that each hypothesis is
true. It will also allow scientists to evaluate the scientiﬁc impor-
tance of the alternative hypothesis that has been favored. Such
reports are particularly important in large sample settings in which
the default alternative hypothesis provided by the UMPBT may
represent only a small deviation from the null hypothesis.
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